TY - JOUR
T1 - Potential role of γδ T cell-derived IL-17 in acute cardiac allograft rejection
AU - Kimura, Naoyuki
AU - Nakae, Susumu
AU - Itoh, Satoshi
AU - Merk, Denis R.
AU - Wang, Xi
AU - Gong, Yongquan
AU - Okamura, Homare
AU - Chang, Paul A.
AU - Adachi, Hideo
AU - Robbins, Robert C.
AU - Fischbein, Michael P.
N1 - Funding Information:
This work was supported by the Falk Research Fund for the Department of Cardiothoracic Surgery at Stanford University Medical School, Stanford, CA; American Association for Thoracic Surgery (Norman E. Shumway award to M.P.F.); by Stanford Dean's Fellowship (N.K.); by Jichi Medical University Young Investigator Fellowship Award (S. I.), and by the Program for Improvement of Research Environment for Young Researchers, The Special Coordination Funds for Promoting Science, and Technology of the Ministry of Education, Culture, Sports, Science, and Technology (S.N.). We thank Dr Yueh-Hsiu Chien for technical advice.
PY - 2012/8
Y1 - 2012/8
N2 - Background: Although αβ T cells are known to participate in the development of acute cardiac allograft rejection, the role of γδ T cells remains poorly understood. We hypothesized that γδ T cells contribute to acute allograft rejection thru interleukin (IL)-17 production. Methods: Donor hearts from FVB mice (H-2 q) were heterotopically transplanted into C57BL/6-wild type (WT) and γδ T cell-deficient (TCRδ -/-) recipient mice (H-2 b). Overall graft survival was monitored. Graft infiltrating cell profile, including γδ T cell subtype, cytokine expression, and myeloperoxidase activity were measured by flow cytometry, TaqMan (Applied Biosystems, Carlsbad, CA) polymerase chain reaction, and myeloperoxidase assay, respectively, on postoperative days 3 and 6. Results: Graft survival was prolonged in TCRδ -/- recipients compared with WT controls. Graft infiltrating cells, including CD45 +, CD4 +, CD8 +, and Gr1 + cells were significantly decreased in TCRδ -/- recipients compared with WT. Donor hearts transplanted into TCRδ -/- recipients had reduced IL-17 and IL-6 messenger RNA expression. Corroborating the gene expression, intracellular cytokine staining showed decreased IL-17 producing cells in TCRδ -/- recipients. Finally, Vγ1 + and Vγ4 + T cells did not produce IL-17, although both represent 20% to 30% total graft infiltrating γδ T cells. Conclusions: The γδ T cells promote acute cardiac allograft rejection, presumably by producing IL-17. The γδ T cell depletion may prove beneficial in prolonging allograft survival by suppressing IL-17 production.
AB - Background: Although αβ T cells are known to participate in the development of acute cardiac allograft rejection, the role of γδ T cells remains poorly understood. We hypothesized that γδ T cells contribute to acute allograft rejection thru interleukin (IL)-17 production. Methods: Donor hearts from FVB mice (H-2 q) were heterotopically transplanted into C57BL/6-wild type (WT) and γδ T cell-deficient (TCRδ -/-) recipient mice (H-2 b). Overall graft survival was monitored. Graft infiltrating cell profile, including γδ T cell subtype, cytokine expression, and myeloperoxidase activity were measured by flow cytometry, TaqMan (Applied Biosystems, Carlsbad, CA) polymerase chain reaction, and myeloperoxidase assay, respectively, on postoperative days 3 and 6. Results: Graft survival was prolonged in TCRδ -/- recipients compared with WT controls. Graft infiltrating cells, including CD45 +, CD4 +, CD8 +, and Gr1 + cells were significantly decreased in TCRδ -/- recipients compared with WT. Donor hearts transplanted into TCRδ -/- recipients had reduced IL-17 and IL-6 messenger RNA expression. Corroborating the gene expression, intracellular cytokine staining showed decreased IL-17 producing cells in TCRδ -/- recipients. Finally, Vγ1 + and Vγ4 + T cells did not produce IL-17, although both represent 20% to 30% total graft infiltrating γδ T cells. Conclusions: The γδ T cells promote acute cardiac allograft rejection, presumably by producing IL-17. The γδ T cell depletion may prove beneficial in prolonging allograft survival by suppressing IL-17 production.
UR - http://www.scopus.com/inward/record.url?scp=84864186983&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84864186983&partnerID=8YFLogxK
U2 - 10.1016/j.athoracsur.2012.03.049
DO - 10.1016/j.athoracsur.2012.03.049
M3 - Article
C2 - 22560321
AN - SCOPUS:84864186983
SN - 0003-4975
VL - 94
SP - 542
EP - 548
JO - Annals of Thoracic Surgery
JF - Annals of Thoracic Surgery
IS - 2
ER -